Novo Nordisk A/S Common Stock (NVO)
Depreciation & Amortization
kr 10.30B
Quarterly · Period ending: · DKK
NVO Depreciation & Amortization
Latest reportedkr 10.30B DKKperiod ending
Latest reportedkr 10.30B DKKperiod ending
NVO Quarterly Depreciation & Amortization · DKK (kr 0.00 → kr 10.30B)
Quarterly Depreciation & Amortization
High-resolution chart · PNG
NVO depreciation & amortization history
Quarterly · DKK. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Depreciation & Amortization (DKK) |
|---|---|
| 10,304,000,000 | |
| 3,536,000,000 | |
| 5,562,000,000 | |
| 7,757,000,000 | |
| 4,833,000,000 | |
| 3,830,000,000 | |
| 5,198,000,000 | |
| 2,150,000,000 | |
| 8,845,000,000 | |
| 2,914,000,000 | |
| 2,992,000,000 | |
| 2,525,000,000 | |
| 2,177,000,000 | |
| 1,719,000,000 | |
| 1,226,000,000 | |
| 2,041,000,000 | |
| 1,636,000,000 | |
| 1,650,000,000 | |
| 2,082,000,000 | |
| 1,349,000,000 | |
| 1,217,000,000 | |
| 1,377,000,000 | |
| 1,379,000,000 | |
| 2,130,000,000 | |
| 1,158,000,000 | |
| 1,086,000,000 | |
| 1,398,000,000 | |
| 2,095,000,000 | |
| 1,110,000,000 | |
| 1,058,000,000 | |
| 1,642,000,000 | |
| 783,000,000 | |
| 768,000,000 | |
| 732,000,000 | |
| 905,000,000 | |
| 706,000,000 | |
| 863,000,000 | |
| 708,000,000 | |
| 1,116,000,000 | |
| 736,000,000 | |
| 717,000,000 | |
| 624,000,000 | |
| 1,015,000,000 | |
| 633,000,000 | |
| 648,000,000 | |
| 663,000,000 | |
| 769,000,000 | |
| 1,183,000,000 | |
| 667,000,000 | |
| 657,000,000 | |
| 645,000,000 | |
| 643,000,000 | |
| 676,000,000 | |
| 691,000,000 | |
| 635,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 615,000,000 | |
| 825,000,000 | |
| 605,000,000 | |
| 684,000,000 | |
| 607,000,000 | |
| 595,000,000 | |
| 581,000,000 | |
| 0 | |
| 657,000,000 | |
| 533,000,000 | |
| 607,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 461,711,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |